Editas Medicine, Inc. EDIT · SEC Filings

website

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative...

Price2.75

Market Cap427.92 M

Float154.83 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

NEWForm 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 5, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2025

News

TYPE

HEADLINE

FILED AT

8-K

NEWEditas Medicine Announces Third Quarter 2026 Results and Business Updates

Nov 9, 2026

8-K

Editas Medicine Receives Approval to Initiate First-in-Human Clinical Trial of EDIT-401 for Hyperlipidemia

Oct 8, 2026

8-K

Editas Medicine Announces Board of Directors Transition and Q2 2026 Financial Results

Aug 5, 2026

8-K

Editas Medicine, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 18, 2026

8-K

Editas Medicine Announces Pricing of $319.4 Million Public Offering

May 26, 2026

8-K

Editas Medicine Suspends "At-the-Market" Offering Program

May 26, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

May 26, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Cantor; Wells Fargo Securities

May 26, 2026

424B5

SHELF OFFERING | Shares amount: 12,500,000 | Share price: $10.00 | Offering amount: $125,000,000.00

Jun 15, 2023

424B5

SHELF OFFERING | Share price: $11.47 | Offering amount: $125,000,000.00

Jun 14, 2023

424B5

Shares of our common stock having an aggregate offering price of up to $300,000,000.-

May 14, 2021

424B5

3,500,000 Shares-

Jan 21, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 9, 2026

S-3

August 2026 SHELF + ATM

Aug 31, 2026

S-3MEF

May 2026 SHELF

May 26, 2026

POS AM

Form POS AM - Post-Effective amendments for registration statement

Mar 5, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 5, 2025

POSASR

Form POSASR - Post-effective Amendment to an automatic shelf registration statement

Mar 5, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT